$12.44 -0.33 (-2.58%)
11/20/2009 4:00 PM

Amylin Pharmaceuticals, Inc. (AMLN)

CAPS Rating: 4 out of 5

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Current Price $12.44 Mkt Cap $1.76B
Open $12.74 P/E Ratio 0.00
Prev. Close $12.77 Div. (Yield) N/A (N/A)
Daily Range $12.42 - $12.77 Volume 1,358,722
52-Wk Range $5.50 - $15.69 Avg. Daily Vol. 2,575,000

AMLN News and Commentary

Caps

How do you think AMLN will perform vs the S&P 500?

Add Stock to Watchlist

All Members

345 Outperform
50 Underperform
 

All-Star Members

102 Outperform
14 Underperform
 

Wall Street

5 Outperform
5 Underperform
 

Top AMLN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

EmmyKaye (93.00)
Submitted January 16, 2009

Based on the statements made by the President of the company during the bio-tech conference conference in San Francisco, the FDA advised the company that they could use the data base on the one million patients already on Byetta, to meet the criteria… More

cubanrafter (< 20)
Submitted September 04, 2008

People are focusing on Pancreatitis.
The real issue is competition. Byetta is an adjunt therapy in uncontrolled patients. Now we have Januvia, who pretty much does the same thing, is oral and cheaper than Byetta. People do not like needles,… More

AMLN VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about AMLN.

Recs

0
Member Avatar topsecret09 (23.38) Submitted: 9/20/2009 4:49:34 PM : Underperform Start Price: $13.10 AMLN Score: +8.38

I love the biotechs,but there Is heavy insider selling here... TS

Recs

0
Member Avatar SmallPimpin (98.44) Submitted: 9/1/2009 5:15:29 PM : Outperform Start Price: $12.49 AMLN Score: -10.61

Mmm...pharmaceuticals...

Recs

0
Member Avatar jo1935 (49.06) Submitted: 8/16/2009 11:02:06 AM : Outperform Start Price: $13.14 AMLN Score: -16.51

Market Cap is 1.87 B. Stock currently trading lower than Market Indexes. Reports indicating that net earnings and operating losses for the 6 months ending in June are down. Analyst recommends are mixed. Valuations are less than industry average. Growth TTM greater than prior TTM. Profit Margins are greater than industry 50 percentile mark. Returns are near or greater than industry 50 percentile mark. Debt ratios are high. Operating Metrics are acceptable. Institutional Stock and Mutual Fund ownership is 93.5%. Finances balance. Short term outlook
is bearish. Intermediate and long term is bullish.

Leaderboard

Find the members with the highest scoring picks in AMLN.

Score Leader

Paradime

Paradime (98.11) Score: +85.69

The Score Leader is the member with the highest score across all their picks in AMLN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
teamtec 69.89 11/24/2008 Outperform 1Y $6.09 +104.27% +36.70% +67.57
embodiedheart 96.21 12/2/2008 Outperform 5Y $6.26 +98.72% +32.16% +66.56
MudgieBoy 63.32 8/28/2006 Underperform 1Y $45.15 -72.45% -10.03% +62.41 1 Comment
ajsiegel 98.52 12/3/2008 Outperform 1Y $6.35 +95.79% +35.04% +60.76
massoudb 94.68 9/20/2006 Underperform 3W $44.36 -71.96% -12.17% +59.79
Gr8Vette 74.92 9/15/2006 Underperform 5Y $44.75 -72.20% -12.44% +59.76 1 Comment
rayinla < 20 9/27/2006 Underperform 1Y $43.96 -71.70% -12.94% +58.76 2 Comments
ina1fool < 20 9/27/2006 Underperform 3W $43.96 -71.70% -12.94% +58.76
gunny69 24.97 10/19/2006 Underperform 1Y $46.65 -73.33% -14.84% +58.50
EngelvonChemie 52.06 3/14/2007 Underperform 1Y $38.15 -67.39% -16.09% +51.30

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackCanaccord 78.23 1/28/2009 Underperform NS $10.80 +15.19% +28.90% +13.71
TrackJimCramer 36.31 10/23/2008 Underperform 3W $11.34 +9.70% +22.45% +12.75
TrackLazardCapit < 20 9/2/2008 Outperform NS $22.40 -44.46% -13.22% -31.24
TrackSoleil 84.11 8/27/2008 Underperform NS $23.81 -47.75% -11.48% +36.27
TrackIcahn 22.83 5/29/2008 Outperform 1Y $31.68 -60.73% -18.38% -42.36 5 Comments
TrackBMOCapital 85.25 4/22/2008 Underperform NS $27.41 -54.62% -17.80% +36.82
TrackCanaccord 78.23 2/12/2008 Underperform NS $30.04 -45.24% -21.64% +23.60 10/7/2008 @ $16.45
TrackRWBaird 81.68 1/15/2008 Outperform NS $35.50 -37.38% -8.56% -28.82 8/27/2008 @ $22.23
TrackZacks 70.74 12/13/2007 Underperform 3M $38.87 -65.73% -33.71% +32.02 10/20/2008 @ $13.32 1 Comment
TrackLehmanBros 66.51 11/1/2007 Underperform NS $44.00 -28.98% -9.36% +19.62 5/28/2008 @ $31.25
TrackEdwardOwens 98.46 9/30/2007 Outperform NS $50.00 -75.12% -24.86% -50.26 2 Comments
TrackJefferies 31.78 9/26/2007 Outperform NS $49.99 -45.69% -10.14% -35.55 6/9/2008 @ $27.15
TrackZacks 70.74 9/11/2007 Underperform 3M $48.72 -6.36% +1.48% +7.84 10/19/2007 @ $45.62 1 Comment
TrackLazardCapit < 20 9/10/2007 Outperform NS $49.24 -48.80% -9.03% -39.78 3/3/2008 @ $25.21
TrackJimCramer 36.31 7/30/2007 Outperform 3W $47.15 -75.95% -36.81% -39.14 10/23/2008 @ $11.34
TrackStanfordRes 78.48 7/24/2007 Outperform NS $44.08 -34.87% -16.87% -18.00 8/19/2008 @ $28.71
TrackGaryBSmith 34.74 5/25/2007 Outperform 3W $44.91 -72.30% -23.73% -48.57
TrackWRHambrecht 53.76 3/13/2007 Outperform NS $38.19 -67.43% -17.31% -50.11
TrackLeerinkSwan 83.04 2/5/2007 Outperform NS $39.00 -77.26% -40.61% -36.64 4/7/2009 @ $8.87
TrackBroadpoint.AmTech 71.55 1/31/2007 Underperform NS $38.93 -68.05% -18.45% +49.59
TrackFBRCapitalM 73.72 1/31/2007 Outperform NS $39.05 -34.98% -10.47% -24.51 6/30/2008 @ $25.39
TrackLazardCapit < 20 8/11/2006 Underperform NS $42.31 -5.32% +14.02% +19.34 4/13/2007 @ $40.06
TrackJimCramer 36.31 2/27/2006 Underperform 3W $43.97 +7.23% +13.48% +6.25 7/31/2007 @ $47.15

Featured Broker Partners